ketamane masterclass

Speaker

Topic

Jason Wallach

Jason Wallach, Ph.D.

Assistant Professor of Pharmaceutical Sciences at University of the Sciences

History, Pharmacology, and Mechanisms of Action

(+ Live Q&A)

In this session you will learn:
  • Brief history of ketamine and related compounds
  • Neuropharmacology of ketamine
  • Ketamine’s activity as an NMDAR antagonist
  • Background on other NMDAR antagonists
  • Differences and similarities between R- and S- ketamine
  • Various hypotheses on ketamine’s antidepressant effects

Abid Nazeer, MD

Founder & President of Advanced Psychiatric Solutions

Screening, Assessment, and Preparation of Patients: How to Track and Monitor Outcomes

(+ Live Q&A)

In this session you will learn:
  • Evidence-based clinical uses of ketamine 
  • Components involved in screening a patient for ketamine including contraindications and cautions 
  • Key principles of informed consent and discharge instructions 
  • Alternative treatment options guidance and how to select the most appropriate ketamine treatment modality with a patient 
  • Treatment strategies involving a patient’s current psychiatric medications in the context of ketamine therapy initiation 
  • How to set up healthy expectations and adequate preparation for patients before, during, and after the treatment course 
  • How to measure and track treatment outcomes
  • Insurance reimbursement options and improving patient access to treatment
Sandhya Prashad MD

Sandhya Prashad, MD

President of American Society of Ketamine Physicians, Psychotherapists & Practitioners

Dosing and Administration: Choosing the Best Approach

(+ Live Q&A)

In this session you will learn:
  • Core differences with Spravato (intranasal esketamine)
  • Long term maintenance of dosing and administration
  • Common routes of ketamine administration including clinical effects, advantages, and disadvantages of each 
  • IV ketamine dosing guidelines and supporting research 
  • Logistics of ketamine administration including optimal patient experience and setting
  • Dosing considerations for oral, intramuscular, and intranasal ketamine
  • How to identify the common, benign, serious, and rare side effects of ketamine 
  • What and how to monitor during infusion (discussion of which vitals to monitor, video monitoring option, remote vital monitoring options, etc.) 
  • How to handle special circumstances that arise during administration including anxiety/panic, nausea, high blood pressure, etc.

Speaker

Topic

Phil Wolfson MD

Phil Wolfson, MD

Director of Ketamine Training Center

Ketamine-Assisted Psychotherapy

(+ Live Q&A)

In this session you will learn:
  • Ketamine-assisted psychotherapy methodology 
  • Treatment implementation techniques 
  • Overview of basic approaches 
  • Principles of high-dose treatments
  • Underlying philosophy 
  • What makes it unique 
  • Limitations and prospects
  • How to best get trained and certified 

Mark Braunstein, DO

Founder and CEO of Reconcious Medical

Matthew

Matthew Campeau, LPC

Founder and CCO of Reconcious Medical

A Model for Virtual Low Dose Ketamine Enhanced Psychotherapy

(+ Live Q&A)

In this session you will learn:
  • Background research on psycholytic psychotherapy 
  • Background research on low dose ketamine as a mental health treatment
  • Neuropsychological and clinical benefits of low dose ketamine on psychotherapy 
  • Need and advantages of low dose KEP 
  • Screening, monitoring, and safety of low dose KEP 
  • Dosing protocols and treatment paths 
  • Overview of the the low dose KEP session 
  • Case examples 
  • How low dose KEP fits with high dose KAP 
  • Therapist modalities and orientation 
  • Disadvantages and questions for further exploration
Adel

Adele Lafrance, Ph.D.

Psychologist and research scientist at Emotion Science

EFKAP: Emotion-Focused Ketamine Therapy

(+ Live Q&A)

In this session you will learn:
  • A brief overview of KAP models
  • A step-by-step review of the EF-KAP model
  • Research data, clinical vignettes, and video clips 
  • Theoretical principles underlying EF-KAP model 
  • Emotion processing 
  • How to facilitate increasing supportive carer involvement 
  • Overview of short-term EF-KAP protocol 
  • Video review 
  • Review of preliminary research with MDD and AN
Brad Bartlett

Brad Bartlett, Esq.

Senior Legal Counsel / Founder Bartlett Law Practice LLC

Ketamine and the Evolving Legal and Regulatory Framework for Psychedelic Medicines

(+ Live Q&A)

In this session you will learn:
  • A brief overview of the three legal pillars of psychedelics (religion/medicine/states’ rights)
  • Principles of psychedelic medicines and liability
  • Legal and regulatory constraints 
  • Safety practices
  • How to prepare for the worst-case scenario
  • Licensing and registration
  • Navigation of the doctor/patient relationship